Home Featured Page 15

Featured

Latest

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and Psychiatry’s, Wild Ride

High Hopes in the Mile High City: Inside Colorado’s First Licensed Psilocybin Center

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

Oakland Psychedelic Conference

Pα+ Psychedelic Bulletin #174: Psilocybin Outperforms Escitalopram After 6 Months… or...

Ancestral Knowledge: Why Understanding the Ancient is Crucial for Western Psychedelic...

Intention, Making Space for Integration, and Finding Joy in the Mundane

The Psychedelic News Feed: March 4, 2024 – September 1, 2024

Pα+ Psychedelic Bulletin #173: Upcoming Trial Readouts to Watch; Lykos Prioritises...

Why Did the FDA Reject MDMA-Assisted Therapy for PTSD?

Could Psychedelics Transform How Doctors Treat Chronic Pain?

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

How to Create Your Own Psychedelic Integration Circle

Real-World Data Reveals Variability in Access to, and Use of, Spravato

1...141516...285 Page 15 of 285

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and...

High Hopes in the Mile High City: Inside Colorado’s First Licensed...

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and Psychiatry’s, Wild Ride

High Hopes in the Mile High City: Inside Colorado’s First Licensed Psilocybin Center

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

Psychedelic Science 2025

Oakland Psychedelic Conference

Pα+ Psychedelic Bulletin #174: Psilocybin Outperforms Escitalopram After 6 Months… or...

Ancestral Knowledge: Why Understanding the Ancient is Crucial for Western Psychedelic...

Intention, Making Space for Integration, and Finding Joy in the Mundane

The Psychedelic News Feed: March 4, 2024 – September 1, 2024

Pα+ Psychedelic Bulletin #173: Upcoming Trial Readouts to Watch; Lykos Prioritises...

Why Did the FDA Reject MDMA-Assisted Therapy for PTSD?

Could Psychedelics Transform How Doctors Treat Chronic Pain?

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

How to Create Your Own Psychedelic Integration Circle

Real-World Data Reveals Variability in Access to, and Use of, Spravato

EDITOR PICKS

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and...

High Hopes in the Mile High City: Inside Colorado’s First Licensed...

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY